PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostPress Release
PHI and Boston Children’s Hospital enter evaluation agreement
PostPress Release
Big Pharma company orders third HoloMonitor
PostPress Release
HoloMonitor provide vital information to development of improved child cancer treatment
PostNews: Press Release
PHI achieves market acceptance goals
Prior to the company’s IPO in early 2014, three market acceptance goals were set out to be achieved by the end of 2015: 50 units in operation at customers and key opinion leaders, collaboration agreements with 8 key opinion leaders and the company’s main product HoloMonitor® M4 shall be manufactured in series production.
PostPress Release
PHI invited to speak at world leading scientific event
PostNews: Press Release
Big Pharma embraces HoloMonitor technology from PHI
Upon completion of an extensive evaluation in early September one of the top pharmaceutical companies in the world has decided to acquire two HoloMonitor® instruments. The ordered configuration is an automated version of the HoloMonitor platform.